Meta description: HPLC vs. UV, marker compounds vs. full-spectrum, COA interpretation — what every B2B botanical extract buyer needs to know before evaluating a supplier.
Target keywords: standardized botanical extract hplc, botanical extract coa interpretation, marker compound extract specification, botanical extract quality control
Suggested URL slug: /knowledge/standardized-extracts-buyers-guide
Reading time: ~10 minutes
—
“Standardized to 25% carnosic acid.” “HPLC verified.” “Full-spectrum extract.” “Marker compound: 5%.”
These phrases appear on virtually every botanical extract datasheet. But they don’t all mean the same thing—and misunderstanding them can lead to procurement decisions that fail your finished product specification, fail regulatory review, or cost significantly more than necessary.
This guide explains what standardization really means, what testing methods are appropriate for different ingredient types, and how to interpret a COA with confidence.
“Standardized to X%” means the extract has been processed to deliver a specific concentration of one or more active compounds. The percentage is measured by a validated analytical method (typically HPLC or UV) and reported on the COA.
Key distinctions that matter:
1. Label claim vs. measured value
The “standardized to 25%” on the label is the target. The actual COA value should be within an acceptable range (typically ±2% for HPLC-measured actives, ±5% for UV-measured actives). A 25% label with a COA showing 19% is failing spec.
2. Active compound vs. marker compound
“Standardized to 25% carnosic acid” means carnosic acid—the pharmacologically active compound—is 25% of the extract. “Standardized to 5% ginsenosides” (using ginsenoside Rg1 as a marker) may mean the total ginsenosides are 5%, but the specific Rg1 content may be 0.5% with Rb1, Rd, Re making up the rest. Always ask which specific compound(s) are measured.
3. Pure extract vs. blended/diluted extract
“Standardized to 25% carnosic acid” can mean either (a) the extract naturally contains 25% carnosic acid with no dilution, or (b) the extract is blended with maltodextrin or another carrier to dilute to exactly 25%. Both are legitimate, but the inclusion rate in your finished product will differ significantly. Always ask: is the extract a pure extract or a diluted blend?
4. Process control vs. certificate of analysis
A supplier that says “standardized” should be able to demonstrate process control (consistent raw material, consistent extraction parameters, consistent testing). A supplier that produces one good batch and labels it “standardized” without process control is unreliable. Ask for 3–5 historical COAs to verify consistency.
The analytical method used to measure active content affects accuracy and applicability.
HPLC (High-Performance Liquid Chromatography):
UV Spectrophotometry:
HPTLC (High-Performance Thin-Layer Chromatography):
Titration:
When to require which method:
For finished product regulatory submissions, HPLC is the gold standard and is generally required. UV is acceptable for “total content” specifications but not for individual compound claims. Always specify the method on your supplier agreements.
This is a critical distinction in product positioning.
Marker compound standardization measures one specific compound (e.g., “standardized to 5% ginsenoside Rg1”). This is common in pharmaceutical and supplement applications where consistency and dosing precision matter.
Full-spectrum extracts aim to retain the full range of compounds present in the original plant material, with a “fingerprint” approach to ensure consistency. These are often positioned as “more natural” or “more bioactive” because the synergy of multiple compounds is preserved.
Practical differences:
| Aspect | Marker-Standardized | Full-Spectrum |
|—|—|—|
| Active content | Specific, measurable | Range-based, fingerprint-matched |
| Cost | Higher (purification required) | Lower |
| Consistency | Higher batch-to-batch | Variable; depends on fingerprint match |
| Regulatory acceptance | Higher (precise claims possible) | Lower (claims must be careful) |
| Marketing position | Pharmaceutical, clinical | Natural, traditional, holistic |
What to choose depends on your application:
Many suppliers offer both. Ask which option they’re quoting and adjust your procurement decision accordingly.
Here’s what to look for in a Certificate of Analysis:
Header information:
Test results table:
Common COA sections:
Red flags in COAs:
Beyond the COA, several other supplier claims warrant scrutiny:
“100% pure”: Meaningless without context. Pure extract? No excipients? No carriers? Ask for the full composition.
“GMP certified”: Verify which GMP (cGMP, PIC/S, ISO 22716, NSF). For finished products, PIC/S or cGMP is required. For ingredient suppliers, ISO 22000 or cGMP is common.
“Organic”: Verify the certification body (USDA, EU, JAS, etc.) and the certificate scope. Some suppliers claim “organic” based on partial certification.
“Food grade”: Verify with the destination market’s specific food safety standards. “Food grade” in China differs from “food grade” in EU.
“Clinically studied”: Ask for the specific study references. Some suppliers cite in-vitro studies or animal studies as “clinical” evidence.
“Best price”: Quality botanical extracts have a market price floor. Pricing significantly below market usually indicates quality compromise.
“Same as [competitor brand]”: Common in low-quality copycat products. Genuine standardized extracts require process control that’s hard to copy.
For ongoing B2B sourcing, build a structured evaluation process:
Our supplier network maintains standardized extract documentation libraries and supports third-party testing coordination. We provide:
We focus on documentation and verification support, not on manufacturing. Our value is helping you evaluate and qualify suppliers, not producing the extract.
Request the COA with the actual measured value (not just the label claim), the analytical method (HPLC recommended), and ideally a sample chromatogram. Cross-check with a third-party lab test of the same batch.
A marker compound is a measurable chemical used to verify the extract’s identity and consistency. An active compound is the one that produces the desired biological effect. Sometimes they’re the same (e.g., carnosic acid is both the marker and the active), but often they’re related but distinct (e.g., ginsenoside Rg1 as marker for total ginsenosides, but multiple ginsenosides contribute to activity).
It depends on the destination market and the specific claim. For most pharmaceutical-grade or health claim applications, HPLC is required. UV is acceptable for some “total content” specifications in food-grade applications. Check with your regulatory consultant for the specific market.
For high-value or high-risk ingredients, test every batch. For lower-risk ingredients, statistical sampling (every 3rd or 5th batch) with periodic full testing may be acceptable. Your QA team should define the testing frequency based on risk assessment.
—
This article is for general information only and does not constitute QA or regulatory advice. For specific supplier evaluation and quality control questions, consult qualified QA/regulatory professionals.
Tags: standardized extract, hplc testing, coa interpretation, marker compound, botanical quality control
Related content:
Southeast Asia Botanical Extract Import Regulations: Thailand, Vietnam, Malaysia, Indonesia Compared Meta description: Side-by-side comparison of botanical extract import requirements…
Trade Show Vitafoods Europe 2026 Recap: Key Trends in Botanical Extract Sourcing June 2026 · 7 min read Our team…
Quality The Complete Guide to COA, MSDS, and Third-Party Testing for Botanical Extracts June 2026 · 9 min read Documentation…
